Progressive multiple sclerosis treatment considerations in the UK: Experience from trials and real-world population
…and extension safety data has been largely reassuring with the most common reported events being upper respiratory tract infections, headache, and raised liver enzymes [84]. The MS-STAT2 trial, investigating the…
Content Section: Articles